BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu J, Cang S, Liu C, Ochiai W, Chiao JW. Development of human prostate cancer stem cells involves epigenomic alteration and PI3K/AKT pathway activation. Exp Hematol Oncol 2020;9:12. [PMID: 32537260 DOI: 10.1186/s40164-020-00168-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Luo X, Cao M, Gao F, He X. YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition. Exp Hematol Oncol 2021;10:35. [PMID: 34088349 DOI: 10.1186/s40164-021-00227-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Shukla RK, Badiye A, Vajpayee K, Kapoor N. Genotoxic Potential of Nanoparticles: Structural and Functional Modifications in DNA. Front Genet 2021;12:728250. [PMID: 34659351 DOI: 10.3389/fgene.2021.728250] [Reference Citation Analysis]
3 Dong B, Li S, Zhu S, Yi M, Luo S, Wu K. MiRNA-mediated EMT and CSCs in cancer chemoresistance. Exp Hematol Oncol 2021;10:12. [PMID: 33579377 DOI: 10.1186/s40164-021-00206-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Mehrpouri M, Momeny M, Bashash D. Synergistic effects of BKM120 and panobinostat on pre-B acute lymphoblastic cells: an emerging perspective for the simultaneous inhibition of PI3K and HDACs. J Recept Signal Transduct Res 2020;:1-9. [PMID: 33969806 DOI: 10.1080/10799893.2020.1853159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Huang S, Gong N, Li J, Hong M, Li L, Zhang L, Zhang H. The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets. Biomark Res 2022;10:18. [PMID: 35392988 DOI: 10.1186/s40364-022-00368-2] [Reference Citation Analysis]